Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jamshid Motalebzadeh"'
Autor:
Jamshid Motalebzadeh, Elaheh Eskandari
Publikováno v:
Breast cancer (Tokyo, Japan). 29(6)
Deciphering new molecules related to the breast cancer subtypes is crucial for prognosis and determining a better strategy for targeted therapy. In this study, we aimed to model ceRNAs networks in luminal A and luminal B subtypes of breast cancer and
Autor:
Jamshid Motalebzadeh, Elaheh Eskandari
Publikováno v:
Medical Oncology. 38
Mechanisms underlying the regulation of gene expression in cancer have been surveyed for decades to find novel prognostic factors and new targets for molecular targeted therapies in cancer. Because most cases of liver cancer are associated with liver
Autor:
Jamshid Motalebzadeh, Elaheh Eskandari
Mechanisms underlying the regulation of gene expression in cancer have been surveyed for decades to find novel prognostic factors and new targets for molecular targeted therapies in cancer. Because most cases of liver cancer are associated with liver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6fd71def43ebfcbf67bdf4f4084cb48
https://doi.org/10.21203/rs.3.rs-531734/v1
https://doi.org/10.21203/rs.3.rs-531734/v1
Autor:
Elaheh Eskandari, Jamshid Motalebzadeh
Publikováno v:
Cancer genetics. 239
Molecular subtypes of breast cancer are associated with differences in prognosis and strategies of molecular targeted therapies. Gene regulatory mechanisms as one of the reasons might modulate these differences. In the present study, we proposed a co
Autor:
Jamshid Motalebzadeh, Elaheh Eskandari
Publikováno v:
Gene Reports. 20:100719
Introduction In our previous study, based on computational biology methods, the role of SNTB1 in colorectal cancer metastasis attracted our attention for further studies. In the presented study, we aimed to elucidate the possible regulatory mechanism
Publikováno v:
Gene. 679
Molecular alterations that occur in cancer have the potential to be considered as either cancer biomarkers or targeted therapies or even both. In the presented study, we aimed to elucidate the gene regulatory network of metastatic colorectal cancer u
Autor:
Jamshid, Motalebzadeh, Samira, Shabani, Saeedeh, Rezayati, Narges, Shakournia, Rezvan, Mirzaei, Bahar, Mahjoubi, Kamal, Hoseini, Frouzandeh, Mahjoubi
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Background: Colorectal cancer (CRC) is one of the most prevalent cancers worldwide. Despite recent progress in diagnosis and treatment, it remains a major health problem and further studies are needed. We here investigated expression profiles of the
Autor:
Frouzandeh Mahjoubi, Younes Hosseinpour, Jamshid Motalebzadeh, Nahid Nafissi, Maria Hashemian, Mohsen Taheri
Publikováno v:
Cancer biomarkers : section A of Disease markers. 19(1)
Background Fibulin-4 (FBLN-4) is an extracellular glycoprotein that is upregulated in some cancer and is khown as prognostic marker in ovarian and cervical cancer. Breast cancer resistance protein (BCRP) is an ATP-binding cassette transporter that fa
Autor:
H.A. Ayoubi, N. Shakournia, Frouzandeh Mahjoubi, Jamshid Motalebzadeh, Elaheh Eskandari, S. Rezayati
Publikováno v:
European Journal of Cancer. 72:S137